If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 2 Similar Profiles
Melanoma Medicine & Life Sciences
Dacarbazine Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Safety Medicine & Life Sciences
Survival Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
fotemustine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2019

  • 8407 Citations
  • 28 h-Index
  • 77 Article
  • 3 Review article
  • 1 Comment/debate
  • 1 Short survey

An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system

Larkin, J., Brown, M. P., Arance, A. M., Hauschild, A., Queirolo, P., Vecchio, M. D., Ascierto, P. A., Krajsová, I., Schachter, J., Neyns, B., Garbe, C., Sileni, V. C., Mandalà, M., Gogas, H., Espinosa, E., Hospers, G., Lorigan, P., Nyakas, M., Guminski, A., Liszkay, G. & 5 othersRutkowski, P., Miller, W., Donica, M., Makrutzki, M. & Blank, C., Jan 1 2019, In : European Journal of Cancer. 107, p. 175-185 11 p.

Research output: Contribution to journalArticle

Multicenter Studies
Melanoma
Safety
Mutation
PLX4032
211 Citations

Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma

Weber, J., Mandala, M., Del Vecchio, M., Gogas, H. J., Arance, A. M., Cowey, C. L., Dalle, S., Schenker, M., Chiarion-Sileni, V., Marquez-Rodas, I., Grob, J-J., Butler, M. O., Middleton, M. R., Maio, M., Atkinson, V., Queirolo, P., Gonzalez, R., Kudchadkar, R. R., Smylie, M., Meyer, N. & 14 othersMortier, L., Atkins, M. B., Long, G. V., Bhatia, S., Lebbé, C., Rutkowski, P., Yokota, K., Yamazaki, N., Kim, T. M., De Pril, V., Sabater, J., Qureshi, A., Larkin, J. & Ascierto, P. A., 2017, In : New England Journal of Medicine. 377, 19, p. 1824-1835 12 p.

Research output: Contribution to journalArticle

211 Citations

Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma

Weber, J., Mandala, M., Del Vecchio, M., Gogas, H. J., Arance, A. M., Cowey, C. L., Dalle, S., Schenker, M., Chiarion-Sileni, V., Marquez-Rodas, I., Grob, J-J., Butler, M. O., Middleton, M. R., Maio, M., Atkinson, V., Queirolo, P., Gonzalez, R., Kudchadkar, R. R., Smylie, M., Meyer, N. & 15 othersMortier, L., Atkins, M. B., Long, G. V., Bhatia, S., Lebbé, C., Rutkowski, P., Yokota, K., Yamazaki, N., Kim, T. M., De Pril, V., Sabater, J., Qureshi, A., Larkin, J., Ascierto, P. A. & Guidoboni, M., 2017, In : New England Journal of Medicine. 377, 19, p. 1824-1835 12 p.

Research output: Contribution to journalArticle

211 Citations

Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma

Weber, J., Mandala, M., Del Vecchio, M., Gogas, H. J., Arance, A. M., Cowey, C. L., Dalle, S., Schenker, M., Chiarion-Sileni, V., Marquez-Rodas, I., Grob, J. J., Butler, M. O., Middleton, M. R., Maio, M., Atkinson, V., Queirolo, P., Gonzalez, R., Kudchadkar, R. R., Smylie, M., Meyer, N. & 15 othersMortier, L., Atkins, M. B., Long, G. V., Bhatia, S., Lebbé, C., Rutkowski, P., Yokota, K., Yamazaki, N., Kim, T. M., De Pril, V., Sabater, J., Qureshi, A., Larkin, J., Ascierto, P. A. & for the CheckMate 238 Collaborators, Nov 9 2017, In : New England Journal of Medicine. 377, 19, p. 1824-1835 12 p.

Research output: Contribution to journalArticle

Melanoma
Recurrence
Poisons
Confidence Intervals
Therapeutics
211 Citations

Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma

Weber, J., Mandala, M., Del Vecchio, M., Gogas, H. J., Arance, A. M., Cowey, C. L., Dalle, S., Schenker, M., Chiarion-Sileni, V., Marquez-Rodas, I., Grob, J-J., Butler, M. O., Middleton, M. R., Maio, M., Atkinson, V., Queirolo, P., Gonzalez, R., Kudchadkar, R. R., Smylie, M., Meyer, N. & 14 othersMortier, L., Atkins, M. B., Long, G. V., Bhatia, S., Lebbé, C., Rutkowski, P., Yokota, K., Yamazaki, N., Kim, T. M., De Pril, V., Sabater, J., Qureshi, A., Larkin, J. & Ascierto, P. A., Nov 9 2017, In : New England Journal of Medicine. 377, 19, p. 1824-1835 12 p.

Research output: Contribution to journalArticle

Melanoma
Recurrence
Confidence Intervals
Survival
Poisons